Main Article Content
There is a steady increase in the incidence of Hashimoto’s autoimmune thyroiditis worldwide. The etiology and pathogenetic mechanisms of its development are unknown. It is believed that the cause may be increasing and rapidly changing antigenic load on the immune system by environmental triggers such as the nature and quality of food, intestinal dysbacteriosis, bacterial, viral and fungal infections. Due to the action of several of these factors or one of them, the intestinal immune system loses the ability to identify antigens that come with food and mistakenly begins to produce antibodies to body tissues. Leading importance in the development of this process is given to intestinal dysbacteriosis. The review analyzes the literature data on the importance of dysbacteriosis and the intestinal immune system in the development of autoimmunity and Hashimoto’s thyroiditis. The natural intestinal microflora is in close and constant contact with the immune system of the mucous membrane. The immune system limits the invasion of intestinal wall tissues by a wide variety of microbes, including potential pathogens that can be ingested with food. Despite immune barriers, bacteria can find ways to cross the epithelial layer. In this case, the mechanisms of bacterial destruction are triggered — phagocytosis and elimination by macrophages. Intestinal dysbacteriosis leads to autoimmune diseases and changes the usual modes of digestion and absorption, the functioning of the mucous membrane and the immune system. Intestinal dysbacteriosis causes a violation of the functional density of its mucous membrane. The essence of this process is that the amount of protein that fills the space between the enterocytes and binds them together, thus forming a protective barrier, is reduced in dysbacteriosis. This process is regulated by a specific protein zonulin, which under physiological conditions regulates the absorption of food ingredients and creates a selective permeability of molecules. In dysbacteriosis, the selective permeability of the intestinal wall is lost. Toxins, products of incomplete hydrolysis and other antigens that create a load on the immune system begin to pass through it. These processes lead to food intolerance, allergies and the development of autoimmunity.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Lee SL. What is the global incidence of Hashimoto thyroiditis?. Available from: https://www.medscape.com/answers/120937-122449/what-is-the-global-incidence-of-hashimoto-thyroiditis. Acceced: 25 Mar 2020.
Pankiv IV. Prevalence of autoimmune thyroiditis among women with vitamin D deficiency. Mìžnarodnij endokrinologìčnij žurnal. 2017;13(5):336-339. doi:10.22141/2224-07126.96.36.1997.110023. (in Ukrainian).
Ferreira RM, Pereira-Marques J, Pinto-Ribeiro I, et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018;67(2):226-236. doi:10.1136/gutjnl-2017-314205.
Berbers RM, Nierkens S, van Laar JM, Bogaert D, Leavis HL. Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences. Trends Immunol. 2017;38(3):206-216. doi:10.1016/j.it.2016.11.008.
Yasmin Noone. Why can't anyone tell you exactly 'why' you have autoimmune thyroiditis? Available from: https://www.sbs.com.au/food/article/2018/05/03/why-cant-anyone-tell-you-exactly-why-you-have-autoimmune-thyroiditis.
Almonacid DE, Kraal L, Ossandon FJ, et al. 16S rRNA gene sequencing and healthy reference ranges for 28 clinically relevant microbial taxa from the human gut microbiome. PLoS One. 2017;12(5):e0176555. doi:10.1371/journal.pone.0176555.
Fiedorová K, Radvanský M, Bosák J, et al. Bacterial but Not Fungal Gut Microbiota Alterations Are Associated With Common Variable Immunodeficiency (CVID) Phenotype. Front Immunol. 2019;10:1914. doi:10.3389/fimmu.2019.01914.
Miyake S, Kim S, Suda W, et al. Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters. PLoS One. 2015;10(9):e0137429. doi:10.1371/journal.pone.0137429.
Gallo A, Passaro G, Gasbarrini A, Landolfi R, Montalto M. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. World J Gastroenterol. 2016;22(32):7186-7202. doi:10.3748/wjg.v22.i32.7186.
Chairatana P, Nolan EM. Defensins, lectins, mucins, and secretory immunoglobulin A: microbe-binding biomolecules that contribute to mucosal immunity in the human gut. Crit Rev Biochem Mol Biol. 2017;52(1):45-56. doi:10.1080/10409238.2016.1243654.
Litwińczuk M, Szydełko J, Szydełko M. The role of gut microbiota in patients with autoimmune thyroid diseases – current status and future perspectives. J Educ Health Sport. 2019;9(9):816-827. doi:10.5281/zenodo.3460391.
Richards JL, Yap YA, McLeod KH, Mackay CR, Mariño E. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology. 2016;5(5):e82. doi:10.1038/cti.2016.29.
Kellman R. Hashimoto's Thyroiditis: We Can Win This Battle!. Available from: https://www.huffpost.com/entry/hashimotos-thyroiditis-we_2_b_7118690.
Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2(9):416-422. doi:10.1038/ncpgasthep0259.
Mindd Foundation. Autoimmune Thyroid Disease Begins with the Diet, Not in the Thyroid. Available from: https://mindd.org/autoimmune-thyroid-disease-begins-diet/.